Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06019845 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The MAGiC™ Cardiac Ablation European Study

Study acronym: MAGiC-FESTPMCF
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jun 2025 to Dec 31, 2027v8 Show 4 more changesShow less
    • Study sites: 2 to 4
    • Study completion date: Sep 2026 to Dec 31, 2028
    • Eligibility criteria shortened, about 41 words
    • Study description expanded, about 1 word
  2. Primary completion date: Feb 2025 to Jun 2025
    • Study completion date: Jun 2026 to Sep 2026
    v7
  3. Primary completion date: Nov 2025 to Feb 2025
    • Study completion date: Apr 2026 to Jun 2026
    v6
  4. Primary completion date: Jun 2025 to Nov 2025
    • Study completion date: Jan 2026 to Apr 2026
    v5
  5. Primary completion date: Jun 2024 to Jun 2025v4
Show 2 earlier versionsHide 2 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 2
    • Start date changed from estimate of Jan 2024 to Jan 2, 2024
    • Study description expanded, about 42 words
    v3
  2. Start date: Nov 2023 to Jan 2024v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the first phase of this feasibility study is to gather safety and performance data on MAGiC to support European marketing approval. The purpose of MAGiC-FEST PMCF Study is to collect safety and performance data with MAGiC to meet ongoing regulatory obligations.
Trial Details
NCT Number NCT06019845
Lead Sponsor Stereotaxis
Collaborators: Osypka AG
Conditions
(from sponsor)		 Arrhythmias, Cardiac
Related terms Arrhythmias, Cardiac, Atrial Fibrillation, Atrial Flutter, Tachycardia, Supraventricular, Tachycardia, Ventricular, Ventricular Premature Complexes
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov